Inhibition of BRCC36 enhances apoptosis by disrupting BRCA1 phosphorylation in breast cancer cells exposed to ionizing radiation.

被引：0
|
作者：
Arciero, CA [1 ]
Chen, X [1 ]
Godwin, AK [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S284 / S284
页数：1
相关论文
共 45 条
  • [21] BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition
    Baoyuan Zhang
    Junfang Lyu
    Yifan Liu
    Changjie Wu
    Eun Ju Yang
    Lakhansing Pardeshi
    Kaeling Tan
    Koon Ho Wong
    Qiang Chen
    Xiaoling Xu
    Chu-Xia Deng
    Joong Sup Shim
    Oncogene, 2018, 37 : 6341 - 6356
  • [22] BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition
    Zhang, Baoyuan
    Lyu, Junfang
    Liu, Yifan
    Wu, Changjie
    Yang, Eun Ju
    Pardeshi, Lakhansing
    Tan, Kaeling
    Wong, Koon Ho
    Chen, Qiang
    Xu, Xiaoling
    Deng, Chu-Xia
    Shim, Joong Sup
    ONCOGENE, 2018, 37 (49) : 6341 - 6356
  • [23] Molecular pathways involved in response to ionizing radiation of ID-8 mouse ovarian cancer cells expressing exogenous full-length Brca1 or truncated Brca1 mutant
    Sylvain, V
    LaFarge, S
    Bignon, YJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (03) : 599 - 607
  • [24] Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation
    Mamon, HJ
    Dahlberg, W
    Azzam, EI
    Nagasawa, H
    Muto, MG
    Little, JB
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2003, 79 (10) : 817 - 829
  • [25] The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells
    Zhou, CY
    Huang, P
    Liu, JS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (03) : 952 - 960
  • [26] Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
    Pessetto, Ziyan Yuan
    Yan, Ying
    Bessho, Tadayoshi
    Natarajan, Amarnath
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 511 - 517
  • [27] Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
    Ziyan Yuan Pessetto
    Ying Yan
    Tadayoshi Bessho
    Amarnath Natarajan
    Breast Cancer Research and Treatment, 2012, 134 : 511 - 517
  • [28] Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: A critical review of the literature
    Drooger, Jan C.
    Hooning, Maartje J.
    Seynaeve, Caroline M.
    Baaijens, Margreet H. A.
    Obdeijn, Inge Marie
    Sleijfer, Stefan
    Jager, Agnes
    CANCER TREATMENT REVIEWS, 2015, 41 (02) : 187 - 196
  • [29] Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
    Ziyan Yuan Pessetto
    Ying Yan
    Tadayoshi Bessho
    Amarnath Natarajan
    Breast Cancer Research and Treatment, 2016, 155 : 613 - 613
  • [30] Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1
    Ratanaphan, Adisorn
    Nhukeaw, Tidarat
    Hongthong, Khwanjira
    Dyson, Paul J.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (02) : 212 - 220
12345